PERICARDITIS
Clinical trials for PERICARDITIS explained in plain language.
Never miss a new study
Get alerted when new PERICARDITIS trials appear
Sign up with your email to follow new studies for PERICARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for heart inflammation sufferers: can one drug replace a cocktail?
Disease control Recruiting nowThis study tests whether people with well-controlled recurrent pericarditis (a painful heart inflammation that keeps coming back) can safely switch from their current combination of medicines to just one drug, KPL-387. About 80 adults whose symptoms are stable will be followed fo…
Matched conditions: PERICARDITIS
Phase: PHASE2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New hope for heart inflammation sufferers: KPL-387 trial launches
Disease control Recruiting nowThis study tests whether a new drug called KPL-387 can safely treat recurrent pericarditis, a condition where the heart's lining becomes inflamed and painful. About 165 adults who still have symptoms despite standard treatments will receive the drug. The goal is to see if it redu…
Matched conditions: PERICARDITIS
Phase: PHASE2, PHASE3 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Rare disease mystery: european study aims to unlock secrets of CACP syndrome
Knowledge-focused Recruiting nowThis study is gathering information from people with CACP syndrome, a rare genetic condition that causes joint problems and sometimes heart issues. Researchers want to learn how the disease progresses and how it affects people differently. The goal is to improve diagnosis and car…
Matched conditions: PERICARDITIS
Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC